Acadia Pharmaceuticals | Passività Correnti



Current Liabilities Cambiamento Data
Acadia Pharmaceuticals USD 330.02M 27.49M 2025-06
ALKERMES USD 505.96M 62.23M 2025-06
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 684.25M 56.03M 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Cytokinetics USD 131.06M 28.66M 2025-06
Eisai JPY 411.61B 39.31B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Incyte USD 1.28B 608.18M 2025-06
J&J USD 56.9B 6.58B 2025-03
Moderna USD 1.57B 32M 2025-06
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Prothena USD 48.5M 2.08M 2024-12
PTC Therapeutics USD 627.81M 32.42M 2025-06
Sarepta Therapeutics USD 919.95M 314.36M 2025-06
Ultragenyx Pharmaceutical USD 293.24M 1.58M 2025-06
Vertex Pharmaceuticals USD 4.14B 355.2M 2025-06


Acadia Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.